CUL4A and osteosarcoma: To validate this hypothesis, we selected a CUL4A-overexpression ovarian cell line SKOV3 and a CUL4B-overexpression osteosarcoma cell line Saos2 and evaluated their cell proliferation abilities in the conditions of 0, 0.2, 2 and 20 μM NSC1892 treatments, respectively.